RHINOCYTE
RhinoCyte engages in the development and commercialization of diagnostic tools and therapies for stem cell treatment of multiple degenerative and traumatic neurological diseases. Its technology facilitates functional recovery in patients, including therapeutic stem cell transplantation with cells from the patient's own nasal cavity eliminating the need for immunosuppressive therapy. The company's technology is used to treat conditions, such as Parkinson's disease, Multiple Sclerosis, Alzheimer's disease, and spinal cord injuries. RhinoCyte, Inc. was founded in 2005 and is based in Louisville, Kentucky.
RHINOCYTE
Industry:
Biotechnology Life Science Medical
Founded:
2005-01-01
Address:
Louisville, Kentucky, United States
Country:
United States
Website Url:
http://www.rhinocyte.com
Total Employee:
1+
Status:
Active
Contact:
(502)410-0399
Email Addresses:
[email protected]
Total Funding:
4.7 M USD
Technology used in webpage:
SPF Amazon Amazon Virginia Region NameBright WordPress 4.0
Similar Organizations
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Current Employees Featured
Founder
Investors List
Queen City Angels
Queen City Angels investment in Series A - RhinoCyte
Keyhorse Capital (KSTC)
Keyhorse Capital (KSTC) investment in Series A - RhinoCyte
Kentucky Seed Capital Fund
Kentucky Seed Capital Fund investment in Series A - RhinoCyte
Official Site Inspections
http://www.rhinocyte.com
- Host name: 172.67.153.75
- IP address: 172.67.153.75
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
